EDITORIAL
Published on 13 Dec 2022
Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes
doi 10.3389/fonc.2022.1100427
- 859 views
- Frontiers in Oncology
- Breast Cancer
- Research Topics
- Recent Advancements in Neoadjuvant Chemotherapy for Specific Breast Cancer Subtypes
Recent Advancements in Neoadjuvant Chemotherapy for Specific Breast Cancer Subtypes
4,471
Total downloads
15k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 29 Nov 2021
Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
doi 10.3389/fonc.2021.657634
- 1,866 views
- 7 citations
ORIGINAL RESEARCH
Published on 12 Aug 2021
Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study
doi 10.3389/fonc.2021.642571
- 2,500 views
- 5 citations
CLINICAL TRIAL
Published on 09 Jul 2021
Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study
doi 10.3389/fonc.2021.645026
- 3,120 views
- 9 citations
ORIGINAL RESEARCH
Published on 08 Jun 2021
Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer
doi 10.3389/fonc.2021.686591
- 5,002 views
- 1 citation
Published in
Frontiers in Oncology
- Breast Cancer
- Women's CancerOffline
Impact
- 15kTopic views
- 9,776Article views
- 4,471Article downloads